REVISITING GVL EFFECT OF AZACITIDINE TREATMENT IN RELAPSED MDS PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

被引：0
|
作者：
Cho, S. G. [1 ]
Kim, S. Y. [1 ]
Cho, B. S. [1 ]
Kim, M. [1 ]
Eom, K. S. [1 ]
Kim, Y. J. [1 ]
Kim, H. J. [1 ]
Lee, S. [1 ]
Min, C. K. [1 ]
Kim, D. W. [1 ]
Lee, J. W. [1 ]
Min, W. S. [1 ]
Park, J. W. [1 ]
Kim, C. C. [1 ]
机构：
[1] Catholic Univ Korea, Seoul, South Korea
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0700
引用
收藏
页码：281 / 281
页数：1
相关论文
共 50 条
  • [31] Combination of Tagraxofusp and Azacitidine Is an Effective Option for Relapsed Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem-Cell Transplantation
    Wang, Song-Yau
    Thomassen, Katrin
    Kurch, Lars
    Opitz, Sabine
    Franke, Georg-Nikolaus
    Bach, Enrica
    Platzbecker, Uwe
    Kayser, Sabine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (07): : E579 - E582
  • [32] Venetoclax Therapy in Chronic Lymphocytic Leukemia Patients Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation
    Perutelli, Francesca
    Boccellato, Elia
    Catania, Gioacchino
    Frustaci, Anna Maria
    Innocenti, Idanna
    Moia, Riccardo
    Quaresmini, Giulia
    Gaidano, Gianluca
    Ladetto, Marco
    Laurenti, Luca
    Rambaldi, Alessandro
    Tedeschi, Alessandra
    Bruno, Benedetto
    Vitale, Candida
    Coscia, Marta
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S325 - S326
  • [33] 5-azacitidine in combination with donor lymphocyte infusions for the treatment of patients with MDS or AML relapsing after allogeneic stem cell transplantation.
    Czibere, Akos
    Graef, Thorsten
    Lind, Jens
    Gattermann, Norbert
    Zohren, Fabian
    Fenk, Roland
    Haas, Rainer
    Kobbe, Guido
    BLOOD, 2006, 108 (11) : 428B - 428B
  • [34] Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation
    B Oran
    S Giralt
    D Couriel
    C Hosing
    E J Shpall
    E de Meis
    I F Khouri
    M Qazilbash
    P Anderlini
    P Kebriaei
    U Popat
    A Carrasco-Yalan
    R E Champlin
    M de Lima
    Leukemia, 2007, 21 : 2540 - 2544
  • [35] Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation
    Oran, B.
    Giralt, S.
    Couriel, D.
    Hosing, C.
    Shpall, E. J.
    de Meis, E.
    Khouri, I. F.
    Qazilbash, M.
    Anderlini, P.
    Kebriaei, P.
    Popat, U.
    Carrasco-Yalan, A.
    Champlin, R. E.
    de Lima, M.
    LEUKEMIA, 2007, 21 (12) : 2540 - 2544
  • [36] Outcome and Mutational Profile in MDS Patients undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Tcvetkov, Nikolai
    Morozova, Elena
    Barkhatov, Ildar
    Moiseev, Ivan
    Barabanshikova, Maria
    Tishkov, Artem
    Bug, Dmitrij
    Izmailova, Ekaterina
    Bondarenko, Sergey
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 571 - 572
  • [37] Decitabine for Relapsed Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
    崔杰克
    肖音
    游泳
    石威
    李青
    罗毅
    蒋林
    仲照东
    Journal of Huazhong University of Science and Technology(Medical Sciences), 2017, 37 (05) : 693 - 698
  • [38] Decitabine for relapsed acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
    Cui, Jie-ke
    Xiao, Yin
    You, Yong
    Shi, Wei
    Li, Qing
    Luo, Yi
    Jiang, Lin
    Zhong, Zhao-dong
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2017, 37 (05) : 693 - 698
  • [39] Decitabine for relapsed acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
    Jie-ke Cui
    Yin Xiao
    Yong You
    Wei Shi
    Qing Li
    Yi Luo
    Lin Jiang
    Zhao-dong Zhong
    Current Medical Science, 2017, 37 : 693 - 698
  • [40] Characteristic of relapse after T cell depleted (TCD) allogeneic hematopoietic stem cell transplantation in patients with advanced MDS
    Tamari, R.
    Chung, S.
    Devlin, S.
    Jakubowski, A.
    Papadopoulos, E.
    Boulad, F.
    Small, T.
    Kernan, N.
    Ponce, D.
    Sauter, C.
    Young, J.
    Giralt, S.
    O'Reilly, R.
    Castro-Malaspina, H.
    LEUKEMIA RESEARCH, 2013, 37 : S122 - S123
12345